HHS Launches Pilot Program of Fast Molecular POC Test for Covid-19
Alaska, Florida, Louisiana, New Jersey, and Texas will receive the first shipments of the test used in the NBA bubble.
Read MorePosted by Laurie Bonner | Nov 19, 2020 | Company News, Covid 19, Molecular Diagnostics |
Alaska, Florida, Louisiana, New Jersey, and Texas will receive the first shipments of the test used in the NBA bubble.
Read MorePosted by Melanie Hamilton-Basich | Nov 18, 2020 | Research, Urinalysis & Toxicology |
Fifty peptides have been identified in the urine of liver fibrosis patients in a new study that could pave the way for a potential diagnostic urine test for the condition.
Read MorePosted by Melanie Hamilton-Basich | Nov 16, 2020 | Dementias & Alzheimer’s, Immunoassay Reagents & test Kits |
The new kit provides highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s.
Read MorePosted by Laurie Bonner | Nov 12, 2020 | Sequencing Systems |
The P3 flow cell offers 1.1 billion reads in a single sequencing run, almost three times more than previously available.
Read MorePosted by Laurie Bonner | Nov 9, 2020 | Immunoassay Instrumentation, POC Instruments |
The microplate reader can be retrofitted for point-of-care clinical testing at urgent care facilities, hospitals, or physicians’ offices.
Read More